Development and preclinical characterization of a humanized antibody targeting CXCL12. [electronic resource]
Producer: 20140401Description: 4433-45 p. digitalISSN:- 1557-3265
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Anti-Inflammatory Agents -- administration & dosage
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Arthritis, Experimental -- drug therapy
- Cell Line, Tumor
- Chemokine CXCL12 -- antagonists & inhibitors
- Cricetinae
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Drug Synergism
- Epitope Mapping
- Female
- Humans
- Mice
- Models, Molecular
- Neoplasm Metastasis
- Neoplasms -- drug therapy
- Protein Conformation
- Tumor Burden -- drug effects
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.